Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/13/2011 | US8076307 Formation/elongation of axon by inhibiting the expression or function of Singar and application to nerve regeneration |
12/13/2011 | US8076306 Compositions and their uses directed to hepcidin |
12/13/2011 | US8076305 Biological pacemakers including mutated hyperpolarization-activated cyclic nucleotide-gated (HCN) channels |
12/13/2011 | US8076304 Methods and compositions for the diagnosis and treatment of cyclin A-1 associated conditions |
12/13/2011 | US8076283 Methods for treating congestive heart failure |
12/13/2011 | US8076148 Cytochrome c protein and assay |
12/13/2011 | US8076142 Rooted plant assay system |
12/13/2011 | US8076141 Nucleotide sequences encoding RAMOSA3 and sister of RAMOSA3 and methods of use for same |
12/13/2011 | US8076139 Processes and compositions for transfecting Chinese hamster ovary (CHO) cells |
12/13/2011 | US8076138 Evolution of whole cells and organisms by recursive sequence recombination |
12/13/2011 | US8076133 Method for obtaining antigen-specific Tr1 regulatory lymphocytes |
12/13/2011 | US8076131 Settings for recombinant adenoviral-based vaccines |
12/13/2011 | US8076130 Plasmid maintenance system for antigen delivery |
12/13/2011 | US8076120 3-hydroxypropionic acid and other organic compounds |
12/13/2011 | US8076116 Nucleic acids encoding class II human histone deacetylases, and uses related thereto |
12/13/2011 | US8076115 Polypeptides having phytase activity and polynucleotides encoding same |
12/13/2011 | US8076114 Cytochrome P450 oxygenases |
12/13/2011 | US8076109 Processes for producing a fermentation product |
12/13/2011 | US8076105 Device and method for high-throughput quantification of MRNA from whole blood |
12/13/2011 | US8076103 Eukaryotic expression system for the incorporation of stable isotopes into proteins |
12/13/2011 | US8076101 Method of detecting the cystic fibrosis transmembrane conductance regulator (CFTR) at cell exterior |
12/13/2011 | US8076100 Genetic engineering; vaccine; induction antibodies |
12/13/2011 | US8076098 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
12/13/2011 | US8076096 Alteration of cell membrane with FasL |
12/13/2011 | US8076091 Gene encoding a multidrug-resistance human P-glycoprotein homologue on chromosome 7P15-21 and uses thereof |
12/13/2011 | US8076074 Balanced translocation in comparative hybridization |
12/13/2011 | US8076071 Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules |
12/13/2011 | US8076068 Method for determining immunostimulatory activity of RNA oligonucleotides |
12/13/2011 | US8075903 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4 |
12/13/2011 | US8075898 Mite allergen |
12/13/2011 | US8075896 Method to enhance an immune response of nucleic acid vaccination |
12/13/2011 | US8075892 Treatment with anti-ErbB2 antibodies |
12/13/2011 | US8075888 Methods of treatment using antibodies to IL-17 homologous polypeptides |
12/13/2011 | US8075886 Method of treatment using an anti-IL-B50 antibody |
12/13/2011 | US8075780 Purification and concentration of synthetic biological molecules |
12/13/2011 | CA2734230C High yielding soybean variety xb29z11 |
12/13/2011 | CA2734228C High yielding soybean variety xr27f11 |
12/13/2011 | CA2734156C High yielding soybean variety xb15c11 |
12/13/2011 | CA2734153C High yielding soybean variety xb25x11 |
12/13/2011 | CA2734150C High yielding soybean variety xb14g11 |
12/13/2011 | CA2734148C High yielding soybean variety xb25q11 |
12/13/2011 | CA2734020C High yielding soybean variety 92y74 |
12/13/2011 | CA2734015C High yielding soybean variety xb12d11 |
12/13/2011 | CA2734013C High yielding soybean variety xb06m11 |
12/13/2011 | CA2734000C High yielding soybean variety xb04q11 |
12/13/2011 | CA2733981C High yielding soybean variety xb25y11 |
12/13/2011 | CA2733962C High yielding soybean variety xb32j11 |
12/13/2011 | CA2733960C High yielding soybean variety xb23k11 |
12/13/2011 | CA2733957C High yielding soybean variety xb16r11 |
12/13/2011 | CA2733955C High yielding soybean variety xb17m11 |
12/13/2011 | CA2733953C High yielding soybean variety xb22p11 |
12/13/2011 | CA2733887C High yielding soybean variety 900y61 |
12/13/2011 | CA2733880C High yielding soybean variety 900y81 |
12/13/2011 | CA2700820C High yielding, soybean cyst nematode and phytophthora resistant soybean variety 91y40 |
12/13/2011 | CA2475821C Group b streptococcus antigens |
12/13/2011 | CA2470743C Corticotropin releasing factor 2 receptor agonists |
12/13/2011 | CA2452806C Water-soluble stabilized self-assembled polyelectrolytes |
12/13/2011 | CA2446197C Use of alpha 1-antichymotrypsin polypeptides, or nucleic acids encoding them, or of a cell which is expressing an act polypeptide, or a nucleic acid encoding it, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds and for identifying pharmacologically active substances |
12/13/2011 | CA2441048C Novel compound for treatment of allergy and asthma |
12/13/2011 | CA2418655C Use of grf1 protein and cells expressing grf1 protein for screening molecules |
12/13/2011 | CA2410663C A cytochrome p450 enzyme associated with the synthesis of .delta. 12-epoxy groups in fatty acids of plants |
12/13/2011 | CA2402238C Polypeptides having neutrophil stimulating activity |
12/13/2011 | CA2383225C Recombinant adenoviruses preparation and adenovirus banks |
12/13/2011 | CA2378373C Production of rhpbgd and new therapeutic methods for treating patients with acute intermittent porphyria (aip) and other porphyric diseases |
12/13/2011 | CA2373071C Tapetum-specific promoters |
12/13/2011 | CA2358520C Soluble receptor br43x2 and methods of using |
12/13/2011 | CA2350165C Novel serine protease bssp6 |
12/13/2011 | CA2267851C Bordetella strain expressing the fha hybrid, liposomes and vaccines |
12/08/2011 | WO2011153501A2 Methods for improving inflammatory bowel disease diagnosis |
12/08/2011 | WO2011153493A2 Biodegradable lipids for the delivery of active agents |
12/08/2011 | WO2011153449A1 Filamentous fungal host strains and dna constructs, and methods of use thereof |
12/08/2011 | WO2011153440A2 Transposon mutagenesis system and methods of use |
12/08/2011 | WO2011153418A2 Compositions and methods for insecticidal control of stinkbugs |
12/08/2011 | WO2011153378A1 Recombinant Production of Steviol Glycosides |
12/08/2011 | WO2011153351A2 Novel modified live-attenuated vaccines (mlv) and subunit vaccines created by dna shuffling against porcine reproductive and respiratory syndrome virus (prrsv) |
12/08/2011 | WO2011153344A2 Engineering complex microbial phenotypes with transcription enhancement |
12/08/2011 | WO2011153342A2 Engineering complex microbial phenotypes with successive integrations of exogenous dna (siedna) |
12/08/2011 | WO2011153325A2 Gene expression profiling for predicting the response to immunotherapy and/or the survivability of melanoma subjects |
12/08/2011 | WO2011153276A2 Stable, functional chimeric cellobiohydrolase class i enzymes |
12/08/2011 | WO2011153253A1 Electronic and biological pacemaker systems |
12/08/2011 | WO2011153235A2 Compositions featuring superoxide dismutase polypeptides having enhanced anti-oxidant activity |
12/08/2011 | WO2011153186A1 Transgenic brassica event mon 88302 and methods of use thereof |
12/08/2011 | WO2011153121A2 A soluble and stable human 5-lipoxygenase |
12/08/2011 | WO2011152884A2 14 gene signature distinguishes between multiple myeloma subtypes |
12/08/2011 | WO2011152722A2 Cloning and exploitation of a functional r-gene from solanum x edinense |
12/08/2011 | WO2011152694A2 Fusion protein having factor vii activity |
12/08/2011 | WO2011152554A1 Method for producing tumor cell |
12/08/2011 | WO2011152525A1 Antibody and use thereof |
12/08/2011 | WO2011152272A1 Method of determining the risk of adverse effects of irinotecan, and kit therefore |
12/08/2011 | WO2011152071A1 Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof |
12/08/2011 | WO2011152043A1 Transgenic reporter system that reveals expression profiles and regulation mechanisms of alternative splicing in mammalian organisms |
12/08/2011 | WO2011151941A1 Composition having activity of inducing proliferation or accumulation of regulatory t cell |
12/08/2011 | WO2011151777A1 Method for the preparation and amplification of representative and strand- specific libraries of cdna for high throughput sequencing, use thereof, kit and cartridges for automation kit |
12/08/2011 | WO2011151721A1 Process for production of fusion proteins using truncated e. coli thioredoxin |
12/08/2011 | WO2011151716A1 Process for the purification of recombinant human il-11 |
12/08/2011 | WO2011151714A1 Modified sak gene for the production of recombinant proteins |
12/08/2011 | WO2011151515A2 Improved production of proteins in filamentous fungi |
12/08/2011 | WO2011151513A1 Method for improved protein production in filamentous fungi |
12/08/2011 | WO2011151512A2 Method for protein production in filamentous fungi |
12/08/2011 | WO2011151428A1 Method for isolating and/or purifying nucleic acid(s) |